For men | For women | |||||||
---|---|---|---|---|---|---|---|---|
Covariate | OR | 95% CI | p | OR | 95% CI | p | ||
Age (years) | .978 | .968 | .990 | < 0.001*** | .968 | .954 | .982 | < 0.001*** |
MAT type | .826 | .590 | 1.16 | 0.286 | 1.06 | .700 | 1.60 | 0.786 |
MAT dose (mg/day) | .996 | .993 | .999 | 0.003** | .997 | .993 | 1.00 | 0.140 |
Years on MAT | .980 | .952 | 1.01 | 0.155 | .965 | .923 | 1.00 | 0.060 |
Opioid-positive urine drug screens (% of total) | .998 | .994 | 1.00 | 0.184 | .998 | .992 | 1.00 | 0.384 |
Physical symptoms | .986 | .970 | 1.00 | 0.098 | .993 | .972 | 1.01 | 0.520 |
Psychological symptoms | .958 | .944 | .973 | < 0.001*** | .962 | .945 | .980 | < 0.001*** |